Engitix Therapeutics
Senior Scientist, ECM biology and 3D models
바이오·생명과학 · 요구 경력 3년+
- 근무지
- London
- 공고일
- 2026. 10. 29.
- 마감
- 마감일 미정
지원하기 Engitix Therapeutics의 Senior Scientist, ECM biology and 3D models 공고 (회사 사이트가 새 창으로 열려요) 이 공고로 내 CV 리뷰하기
내 CV에 맞는 바이오·생명과학 공고는?무료, 첫 체험은 로그인 없이CV 매칭하기 →영국 비자 스폰서
스폰서 가능성 높음스폰서 라이선스 있음 · A rating
Engitix Limited: gov.uk 스폰서 라이선스 등록부에 있는 회사예요.
등급: A rating
비자 경로: Skilled Worker
라이선스가 있다는 건 스폰서를 할 수 있다는 뜻이고, 이 공고를 스폰서해 준다는 약속은 아니에요. 공고를 확인하세요.
Engitix Therapeutics 영국 비자 스폰서 여부와 열린 공고직무 소개
Your mission
Engitix Therapeutics is a pioneering biotech company dedicated to unlocking extracellular matrix biology to develop transformative therapeutics in fibrosis and oncology. We are seeking an accomplished Senior Scientist in extracellular matrix (ECM) biology and 3D models to take a leading role in understanding disease-associated ECM remodelling, developing translational tissue- and ECM-derived disease models, and identifying and validating novel therapeutic targets in fibrosis and cancer.
The role
We are looking for a scientist with deep expertise in ECM biology and disease-relevant experimental models. The successful candidate will investigate the mechanisms responsible for ECM remodelling in fibrosis and cancer, including ECM deposition and assembly, post-translational modification, and degradation, and translate these insights into target discovery and validation strategies.
A major focus of the role will be the development and application of tissue-derived and ECM-based models of fibrosis and cancer, including precision-cut tissue slices, primary tissue-derived ECM systems, decellularised matrices and complex 3D cellular models, for target validation, mechanistic studies and therapeutic testing.
The successful candidate will work across internal programmes and partnership workstreams, applying tissue-based models alongside cellular, biochemical, molecular biology, imaging and proteomic approaches to understand ECM biology, validate therapeutic targets and evaluate novel therapeutic agents.
What you'll do:
Drive experimental studies investigating ECM remodelling mechanisms in fibrosis and cancer, including matrix deposition, post-translational modification, proteolytic degradation and generation of biologically active ECM products
Develop, optimise and implement translational tissue-derived models of fibrosis and cancer, including precision-cut tissue slices and other ex vivo primary human tissue systems, for mechanistic studies, target validation and therapeutic testing
Develop and optimise ECM-derived and ECM-based 3D disease models, including decellularised tissue matrices, tissue-derived ECM preparations and relevant primary-cell co-cultures
Establish robust and reproducible functional readouts capturing disease-relevant ECM remodelling, stromal-cell phenotypes and therapeutic responses for target discovery workflows
Support proteomic and peptidomic approaches using primary tissues, ECM preparations and disease models to characterise ECM remodelling and enable target discovery and validation
Collaborate with computational and data-science teams to integrate experimental findings with large-scale omics and screening datasets, identify mechanistic and therapeutic hypotheses, and refine functional screening strategies
Analyse and critically interpret experimental data, maintain high-quality records, and communicate findings through reports and presentations
Your profile
Deep expertise in extracellular matrix biology, with a strong mechanistic understanding of ECM remodelling mechanisms in disease
Demonstrated hands-on experience developing and applying complex tissue-derived and/or 3D experimental models, ideally including precision-cut tissue slices, primary human tissue models, decellularised matrices/scaffolds, hydrogel-based systems, or complex co-culture platforms
Experience developing robust functional and phenotypic readouts for target validation, mechanistic studies and/or therapeutic testing
Experience working with primary stromal-cell populations, including fibroblasts and cancer-associated fibroblasts (CAFs), in disease-relevant contexts.
Expertise in relevant imaging and tissue-analysis techniques, including immunofluorescence and quantitative analysis of tissue sections
Hands-on experience with relevant biochemical and molecular biology techniques, which may include MSD or related immunoassays, RNA/DNA extraction, qRT-PCR, western blotting and gene knockdown approaches
Hands-on experience in or familiarity with proteomics and/or peptidomics, particularly where applied to ECM biology, tissue samples or disease mechanisms
Familiarity with analysis or interpretation of large-scale omics or functional screening datasets
Experience in fibrosis, oncology and/or translational drug discovery, particularly in an industry or industry-collaborative environment, would be advantageous
PhD in Biomedical sciences, Tissue Engineering, Biochemistry, Biotechnology or related discipline, plus 3 years’ experience in academia or industry, or equivalent
Ability to plan, execute and critically assess experiments independently
Strong scientific judgement, including the ability to identify appropriate controls, recognise experimental limitations and troubleshoot technically challenging assays and models
Why us?
Be part of a pioneering biotech transforming drug discovery through ECM biology
Work in a collaborative, fast-paced environment with opportunities to shape the future of targeted therapeutics
We offer a competitive package including private medical insurance, pension, bonus, employee perks and more!
지원하기 Engitix Therapeutics의 Senior Scientist, ECM biology and 3D models 공고 (회사 사이트가 새 창으로 열려요)다른 회사의 비슷한 공고
- Global Clinical Study Delivery Graduate Programme, UK, 2027 · GSKLondon
- Life Sciences Program Manager/Program Executive · SalesforceLondon
- Life Sciences Program Manager/Program Executive · SalesforceLondon
- Life Sciences Program Manager/Program Executive · SalesforceLondon
- Clinical Trial Site Relationship Coordinator · MedpaceLondon